Client News
Medigene AG Expands Intellectual Property Rights for its Costimulatory Switch Proteins to Additional Immune Cell Types
Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies
Destiny Pharma: Notice of Interim Results
ViGeneron Announces EMA Approval of Clinical Trial Application for VG901, a Gene Therapy to Treat Retinitis Pigmentosa
Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland
Abivax secures up to EUR 150m from two structured debt financing transactions
Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update
Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
InflaRx Reports Second Quarter 2023 Financial Results & Operating Update
